Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
出版年份 2020 全文链接
标题
Methylation markers
FAM19A4
and
miR124
‐2
as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-10-01
DOI
10.1002/ijc.33320
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
- (2019) Kate T Simms et al. LANCET ONCOLOGY
- Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study
- (2019) Arno Floore et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Triaging HPV positive women with normal cytology or low grade dyskaryosis: evidence from 10 year follow‐up of the ARTISTIC trial cohort
- (2019) Clare Gilham et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
- (2019) P.J. Maver et al. CLINICAL MICROBIOLOGY AND INFECTION
- Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis
- (2019) Stèfanie Dick et al. GYNECOLOGIC ONCOLOGY
- FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
- (2019) Frederique J. Vink et al. INTERNATIONAL JOURNAL OF CANCER
- The use of molecular markers for cervical screening of women living with HIV in South Africa
- (2019) Wieke W. Kremer et al. AIDS
- Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
- (2019) Clare A. Aitken et al. BMC Medicine
- Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up
- (2018) Lise M.A. De Strooper et al. INTERNATIONAL JOURNAL OF CANCER
- Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
- (2018) Wina Verlaat et al. Epigenetics
- The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium
- (2018) Jesper Bonde et al. JOURNAL OF CLINICAL VIROLOGY
- Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention
- (2016) Attila T. Lorincz ACTA CYTOLOGICA
- FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
- (2016) Roosmarijn Luttmer et al. BRITISH JOURNAL OF CANCER
- Validation of the FAM19A4 / mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
- (2016) Lise M.A. De Strooper et al. GYNECOLOGIC ONCOLOGY
- Use of HPV testing for cervical screening in vaccinated women-Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study
- (2016) Ramya Bhatia et al. INTERNATIONAL JOURNAL OF CANCER
- The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
- (2016) Ditte Ejegod et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)
- (2016) Grazyna Stanczuk et al. BMJ Open
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
- (2015) Christine Bergeron et al. JNCI-Journal of the National Cancer Institute
- Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
- (2015) Christine Bergeron et al. JNCI-Journal of the National Cancer Institute
- ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
- (2014) HC Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- CADM1,MALandmiR124-2methylation analysis in cervical scrapes to detect cervical and endometrial cancer
- (2014) Lise M A De Strooper et al. JOURNAL OF CLINICAL PATHOLOGY
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
- (2012) D C Rijkaart et al. BRITISH JOURNAL OF CANCER
- Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
- (2012) M. A. Clarke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
- (2011) M. Poljak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis
- (2009) Renée M Overmeer et al. JOURNAL OF PATHOLOGY
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search